Immunohistochemical Localization of Galectins-1 and -3 and Monitoring of Tissue Galectin-binding Sites During Tubular Regeneration After Renal Ischemia Reperfusion in the Rat
Overview
Pathology
Authors
Affiliations
Endogenous lectins act as effectors of cellular activities such as growth regulation, migration and adhesion. In this study, we report the histochemical detection of galectins and their binding sites in rat kidneys after ischemic injury (35 min) with regard to renal regeneration. In this context, we have shown in a previous publication (Vansthertem et al., 2008) that extrarenal cells (CD44+, vimentin +) could be involved in this process of tubular restoration. In controls, galectin-1 is expressed by fusiform-shaped cells within cortical and medullar interstitium. Two days after ischemia, the number of positive interstitial cells increased temporarily within OSOM in the vicinity of altered tubules to later reach control level. After ischemia, we identified a population of galectin-3 (+), CD44 (+), and vimentin (+) interstitial round cells located in the outer stripe of outer medulla (OSOM) in the vicinity of necrotic tubules, but also in the lumen of adjacent blood vessels. The immunocytochemical characteristics of theses cells, along with their distribution within OSOM, suggest the involvement of a unique cell population during kidney regeneration. On the other hand, the distribution and density of binding sites for galectins within OSOM were not modified after ischemia and remained similar to controls. Altogether, our observations suggest that galectin-3 may be involved in the complex process of kidney regeneration following ischemia/reperfusion injury.
Galectin-3 in Kidney Diseases: From an Old Protein to a New Therapeutic Target.
Boutin L, Depret F, Gayat E, Legrand M, Chadjichristos C Int J Mol Sci. 2022; 23(6).
PMID: 35328545 PMC: 8952808. DOI: 10.3390/ijms23063124.
The Role of Mitochondria in Immune-Cell-Mediated Tissue Regeneration and Ageing.
Su Y, Wang P, Weng S Int J Mol Sci. 2021; 22(5).
PMID: 33800867 PMC: 7961648. DOI: 10.3390/ijms22052668.
Fanfone D, Stanicki D, Nonclercq D, Port M, Vander Elst L, Laurent S Biology (Basel). 2020; 9(3).
PMID: 32183292 PMC: 7150867. DOI: 10.3390/biology9030053.
Ozkurt S, Dogan I, Ozcan O, Fidan N, Bozaci I, Yilmaz B Int Urol Nephrol. 2019; 51(7):1191-1197.
PMID: 31012038 DOI: 10.1007/s11255-019-02156-8.
Pharmacological treatment with galectin-1 protects against renal ischaemia-reperfusion injury.
Carlos C, Silva A, Gil C, Oliani S Sci Rep. 2018; 8(1):9568.
PMID: 29934646 PMC: 6015078. DOI: 10.1038/s41598-018-27907-y.